Ticagrelor IP Impurity B
| CAS No. | : 1788033-05-5 |
| Mol F. | : C23H28F2N6O4S |
| Mol W. | : 522.57 |
| Cat No. | : SA32508 |
- Description
- Quick Enquiry / RFQ
Description
| Product Name | Ticagrelor IP Impurity B |
| Synonyms | (1S,2S,3R,5S)-3-(3-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ylamino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Related API | Ticagrelor |
| Category | Impurities |
Ticagrelor IP Impurity B product with CAS: 1788033-05-5 is also known as (1S,2S,3R,5S)-3-(3-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ylamino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol; . This product can be used as a working standard or secondary reference standard (additional internal validation as per respective FDA regulations/guidelines may require). Ticagrelor IP Impurity B is used in Ticagrelor impurity profiling as per limits and threshold values specified by respective drug legislation, FDA, and pharmacopoeial guidelines during commercial production of Ticagrelor and its related formulations. Moreover, (1S,2S,3R,5S)-3-(3-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ylamino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol is also used in the process of Abbreviated New Drug Application (ANDA) filing to FDA and toxicity study of respective drug formulation. Please also find out other impurities of Ticagrelor developed in our R&D.
Product quantity / packs as per your requirement, just let us know!
Please contact us or email us at [email protected]
